|
| N = 139 |
| Age-year | 54.6 ± 9.9 |
| Male sex―n. (%) | 90 (64.8) |
| Race―n. (%) |
|
| African American | 16 (11.5) |
| Caucasian | 91 (65.5) |
| Hispanic | 32 (23.0) |
| Etiology of cirrhosis―n. (%)* |
|
| HCV | 69 (49.6) |
| Alcohol | 86 (61.2) |
| HBV | 2 (1.4) |
| NAFLD | 11 (7.9) |
| Autoimmune | 6 (4.3) |
| Other† | 9 (6.5) |
| Reason for admission―n. (%)* |
|
| Variceal Bleeding | 37 (26.6) |
| Ascites | 54 (38.9) |
| Hepatic Encephalopathy | 50 (36.0) |
| Coagulopathy | 4 (2.9) |
| SBP | 7 (5.0) |
| Abdominal Pain | 16 (11.5) |
| Other‡ | 12 (8.6) |
| Hepatologist involved in patients’ care―n. (%)§ | 117 (84.2) |
| 30 day re-admission―n. (%) | 43 (31.0) |
| Procedures―n. (%)* |
|
| Paracentesis | 54 (38.9) |
| EGD | 45 (32.3) |
| Colonoscopy | 5 (3.6) |
| TIPS | 6 (4.3) |
| Liver Biopsy | 3 (2.2) |
| ICU level of care―n. (%) | 46 (33.1) |
| Mortality―n. (%) | 12 (8.6) |
| Comorbidity―n. (%) |
|
| Heart Disease | 16 (11.5) |
| Diabetes | 27 (19.4) |
| Renal Failure¶ | 44 (31.7) |
| COPD | 5 (3.6) |
| HIV | 2 (1.4) |
| Malignancy‖ | 35 (25.2) |